Status | Study |
Recruiting |
Study Name: Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation Condition: Haematological Malignancy Date: 2017-05-07 Interventions: Drug: Nivolumab Injection Human monoclonal antibody targeting programmed death-1 (PD-1) cell surface rec |
Not yet recruiting |
Study Name: Prophylactic Early PN in HPT/BMT Condition: Hematologic Neoplasms Date: 2017-03-08 Interventions: Dietary Supplement: Parenteral nutrition. |
Recruiting |
Study Name: A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy Condition: Hematologic Neoplasms Date: 2016-09-06 Interventions: Drug: Itraconazole Participant |
Recruiting |
Study Name: Phase I Trial of BAY1251152 for Advanced Blood Cancers Condition: Hematologic Neoplasms Date: 2016-04-18 Interventions: Drug: BAY1251152 Weekly infusion of BAY1251152 in 21-day cycles. |
Recruiting |
Study Name: Platelet Transfusion Requirements in Hematopoietic Transplantation Condition: Hematologic Neoplasms Date: 2016-01-06 Interventions: Drug: Tranexamic Acid |
Recruiting |
Study Name: Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients Condition: Hematologic Neoplasms Date: 2015-11-30 Interventions: Procedure: Allogeneic (Allo) hematopoietic stem cell transplantation |
Recruiting |
Study Name: Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units Condition: Hematologic Neoplasms Date: 2015-07-17 Interventions: Procedure: T-Cell replete haplo-transplant Infusion of haploidentical related donor peripheral blood ste |
Recruiting |
Study Name: Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant Condition: Hematologic Neoplasms Date: 2015-05-18 Interventions: Biological: BPX-501 Biological |
Recruiting |
Study Name: A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers Condition: Hematologic Neoplasms Date: 2015-02-13 Interventions: Drug: CC-90002 Drug: Rituximab |
Recruiting |
Study Name: A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies Condition: Hematologic Neoplasms Date: 2014-12-30 Interventions: Drug: Ibrutinib Participants w |